Mechanism of Non-alcoholic Steatohepatitis Improved by Qizhu Prescription Based on AMPK Signaling Pathway
10.13422/j.cnki.syfjx.20232237
- VernacularTitle:基于AMPK信号通路探讨芪术方改善非酒精性脂肪性肝炎的机制
- Author:
Qiuyi ZHANG
1
;
Zhenhua ZHOU
1
Author Information
1. Shuguang Hospital,Shanghai University of Traditional Chinese Medicine(TCM), Shanghai 201203,China
- Publication Type:Journal Article
- Keywords:
Qizhu prescription;
non-alcoholic steatohepatitis;
adenylate activated protein kinase (AMPK) pathway;
lipid metabolism;
oxidative stress
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(8):49-56
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the effect and mechanism of Qizhu prescription on liver lipid anabolism and oxidative stress in mice with non-alcoholic steatohepatitis (NASH) based on adenylate activated protein kinase (AMPK) signaling pathway. MethodA total of 60 male C57BL/6J mice were randomly divided into a normal group (n = 10) and a modeling group (n = 50). The modeling group was fed by high-fat and high-cholesterol diet for 16 weeks to establish the NASH mice model and was randomly divided into model group, low-, medium, and high-dose groups of Qizhu prescription, and Yishanfu group, with 10 mice in each group. Qizhu prescription was administered intragastrically once a day at a dose of 4.75, 9.50, and 19.00 g·kg-1 in each group and 228 mg·kg-1 in Yishanfu group. The normal group and model group were given equal volumes of pure water for eight weeks. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), and glucose (GLU) levels were detected. The pathological changes of liver tissue were observed by hematoxylin-eosin (HE) and oil red O staining. Serum levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), free fatty acids (FFA), reduced glutathione (GSH), malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD) were detected by enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of acetyl-CoA carboxylase (ACC), carnitine palmitoyl transferase 1A(CPT1A), and mitochondrial uncoupling protein 2 (UCP2) were detected by real-time fluorescence quantitative polymerase chain reaction (Real-time PCR). Protein expression levels of AMPK, p-AMPK, ACC, CPT1A, and UCP2 in liver tissue were detected by Western blot. ResultCompared with the normal group, the liver steatosis of the model group was obvious, with multiple inflammatory clusters and large amounts of intracellular lipid deposition. The activity of serum AST, ALT, as well as levels of IL-6, IL-1β, TNF-α, FFA, and MDA were significantly increased, the activity of CAT and SOD was significantly decreased, and the mRNA and protein expressions of ACC were significantly increased. The mRNA and protein expressions of CPT1 and UCP2 were significantly decreased, and the protein expression of p-AMPK was significantly decreased (P<0.01). Compared with the model group, the degree of liver steatosis in the Qizhu prescription and Yishanfu groups was reduced, the activity of AST and ALT, as well as the levels of IL-6, IL-1β, TNF-α, FFA, and MDA was significantly decreased, and the activity of CAT and SOD was significantly increased (P<0.01). The mRNA and protein expressions of ACC in liver tissue of mice in medium- and high-dose groups of Qizhu prescription were significantly decreased, while the mRNA and protein expressions of CPT1A and UCP2, as well as p-AMPK protein were significantly increased (P<0.01). ConclusionQizhu prescription can improve liver lipid metabolism, reduce oxidative stress, and promote liver cell repair in NASH mice by activating the AMPK signaling pathway.